000 | 01988 a2200553 4500 | ||
---|---|---|---|
005 | 20250515111841.0 | ||
264 | 0 | _c20080801 | |
008 | 200808s 0 0 eng d | ||
022 | _a0006-8993 | ||
024 | 7 |
_a10.1016/j.brainres.2008.01.051 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAgari, Takashi | |
245 | 0 | 0 |
_aIntrapallidal metabotropic glutamate receptor activation in a rat model of Parkinson's disease: behavioral and histological analyses. _h[electronic resource] |
260 |
_bBrain research _cApr 2008 |
||
300 |
_a189-96 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdrenergic Agents _xtoxicity |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
650 | 0 | 4 |
_aDioxolanes _xpharmacology |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xpharmacology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlobus Pallidus _xmetabolism |
650 | 0 | 4 |
_aMethoxyhydroxyphenylglycol _xanalogs & derivatives |
650 | 0 | 4 |
_aMotor Activity _xdrug effects |
650 | 0 | 4 |
_aOxidopamine _xtoxicity |
650 | 0 | 4 |
_aParkinson Disease _xetiology |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-fos _xmetabolism |
650 | 0 | 4 |
_aPurines _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptors, Metabotropic Glutamate _xmetabolism |
650 | 0 | 4 |
_aSubstantia Nigra _xdrug effects |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xmetabolism |
700 | 1 | _aYasuhara, Takao | |
700 | 1 | _aMatsui, Toshihiro | |
700 | 1 | _aKuramoto, Satoshi | |
700 | 1 | _aKondo, Akihiko | |
700 | 1 | _aMiyoshi, Yasuyuki | |
700 | 1 | _aShingo, Tetsuro | |
700 | 1 | _aBorlongan, Cesario V | |
700 | 1 | _aDate, Isao | |
773 | 0 |
_tBrain research _gvol. 1203 _gp. 189-96 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.brainres.2008.01.051 _zAvailable from publisher's website |
999 |
_c17816584 _d17816584 |